In a regulatory filing, Intra-Cellular director Joel Marcus disclosed the sale of 10,000 common shares of the company on August 11 at a price of $59.22 per share.

The Board of Directors declared a regular dividend distribution of 35.7c per share for the second quarter, an increase of 20% from the 29.75c per share of the first quarter. This dividend will be payable on September 6 to stockholders of record on August 22. The Board also authorized the company to repurchase an additional $500M of shares of its common stock under its existing share repurchase program. As of August 12, approximately 9.8M shares of common stock had been acquired at an aggregate purchase price of approximately $600M since the inception of its initial share repurchase program in 2011. After the expansion of the size of the current program, and as of August 12, an aggregate of approximately $550M will be available for purchase under the program.

Algoma Steel announced that United Steelworkers Local 2251 have agreed to take the company's last offer to a vote by employees in the affected bargaining unit. Operations will continue in the ordinary course during the voting process, and the Union has agreed to provide advance notice to the company to allow for a safe and orderly shutdown of operations in the event the Union instructs employees to go on strike. Algoma President and Chief Executive Officer Michael Garcia commented. "We respect the collective bargaining process and are pleased that our employees will have their say on a matter of such critical importance to their livelihoods, the lives of their families, and fellow community members. The Company has offered a non-concessionary, top-of-market wage and benefit package which includes a 5.5% wage increase, continuation of COLA, significant improvements in pensions and benefits for employees, and enhanced retiree benefits over a four-year term that delivers the stability needed to ensure a successful transition to electric arc steelmaking. A signing bonus is also included contingent upon no disruption to operations and uninterrupted shipments to our customers."

Akumin provided a business update and announced the termination of employment of its CFO, William Larkin and the appointment of David Kretschmer as Interim CFO, effective August 12. The company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The company is receiving support from a globally recognized transformation specialist to help implement the program. As a part of this transformation, the company announced: (a) the termination of employment of its CFO, William Larkin, and the appointment of David Kretschmer, an experienced transformation finance executive who successfully completed other business transformations in the healthcare industry, as Interim CFO, effective August 12; and (b) the sale of certain accounts receivables by subsidiaries of the company to a third-party buyer for a purchase price of approximately $30M.

Edoc Acquisition Corp., a special purpose acquisition company, announced the termination of its previously announced agreement and plan of merger with Calidi Biotherapeutics. Although Edoc and Calidi may continue to discuss the possibility of engaging in a business combination, there can be no assurance that those discussions will result in a transaction between Edoc and Calidi proceeding on the current terms of the Business Combination, if at all. As a result of the termination of the Merger Agreement, Edoc intends to promptly begin simultaneously evaluating other possible business combination targets.

Nelson Peltz's Trian Fund Management disclosed in an SEC filing its holdings as of June 30, 2022. The fund increased its stake in three holdings during the second quarter, including by size of previous position Ferguson (FERG), General Electric (GE), and Invesco (IVZ). Trian reduced its stake in two holdings, including by size of previous position Sysco (SYY) and Mondelez (MDLZ). The fund's top holdings as of June 30, in order of size, were Ferguson, Invesco, Janus Henderson (JHG), Sysco, and Wendy's (WEN).